Ms Myriam MendilaChief Scientific Officer at CureVacSpeaker
Agenda Sessions
Development of an mRNA Based Off-The-Shelf Cancer Vaccine for Treatment Of Glioblastoma
, 15:05View SessionFuture of RNA Therapeutics
, 16:35View Session